Alexander Turpie

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Karthikeyan Ganesan; Eikelboom John W; Turpie Alexander G G; Hirsh Jack
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?
Turpie Alexander G G; Lassen Michael R; Davidson Bruce L; Bauer Kenneth A; Gent Michael; Kwong Louis M; Cushner Fred D; Lotke Paul A; Berkowitz Scott D; Bandel Tiemo J; Benson Alice; Misselwitz Frank; Fisher William D;
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
Turpie Alexander G G; Lensing Anthonie W A; Fuji Takeshi; Boyle Duane A
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Alexander Turpie (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Karthikeyan Ganesan; Eikelboom John W; Turpie Alexander G G; Hirsh Jack
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?
British journal of haematology 2009;146(2):142-9.
2009: Turpie Alexander G G; Lassen Michael R; Davidson Bruce L; Bauer Kenneth A; Gent Michael; Kwong Louis M; Cushner Fred D; Lotke Paul A; Berkowitz Scott D; Bandel Tiemo J; Benson Alice; Misselwitz Frank; Fisher William D;
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
Lancet 2009;373(9676):1673-80.
2009: Turpie Alexander G G; Lensing Anthonie W A; Fuji Takeshi; Boyle Duane A
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(2):114-21.
2009: Turpie Alexander G G; Bauer Kenneth A; Davidson Bruce L; Fisher William D; Gent Michael; Huo Michael H; Sinha Uma; Gretler Daniel D;
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Thrombosis and haemostasis 2009;101(1):68-76.
2008: Kearon Clive; Julian Jim A; Kovacs Michael J; Anderson David R; Wells Philip; Mackinnon Betsy; Weitz Jeffrey I; Crowther Mark A; Dolan Sean; Turpie Alexander G; Geerts William; Solymoss Susan; van Nguyen Paul; Demers Christine; Kahn Susan R; Kassis Jeannine; Rodger Marc; Hambleton Julie; Gent Michael; Ginsberg Jeffrey S;
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
Blood 2008;112(12):4432-6.
2008: Spyropoulos Alex C; Turpie Alexander G G; Dunn Andrew S; Kaatz Scott; Douketis James; Jacobson Alan; Petersen Hans;
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
The American journal of cardiology 2008;102(7):883-9.
2008: Lassen Michael R; Ageno Walter; Borris Lars C; Lieberman Jay R; Rosencher Nadia; Bandel Tiemo J; Misselwitz Frank; Turpie Alexander G G;
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
The New England journal of medicine 2008;358(26):2776-86.
2008: Fisher William D; Turpie Alexander G G
Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;178(12):1571-2.
2008: LeLorier Jacques; Bell Alan; Bougher David J; Cox Jafna L; Turpie Alexander G G
Drug reimbursement policies in Canada--need for improved access to critical therapies.
The Annals of pharmacotherapy 2008;42(6):869-73.
2008: Lassen Michael R; Dahl Ola; Mismetti Patrick; Zielske Dirk; Turpie Alexander G G
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) study.
Journal of the American College of Cardiology 2008;51(15):1498-504.
2008: Turpie Alexander G G
New oral anticoagulants in atrial fibrillation.
European heart journal 2008;29(2):155-65.
2008: Turpie Alexander G G
The top 4 advances in antithrombotic care in the last year.
Thrombosis research 2008;123 Suppl 1():S2-6.
2008: Mueck Wolfgang; Eriksson Bengt I; Bauer Kenneth A; Borris Lars; Dahl Ola E; Fisher William D; Gent Michael; Haas Sylvia; Huisman Menno V; Kakkar Ajay K; Kälebo Peter; Kwong Louis M; Misselwitz Frank; Turpie Alexander G G
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
Clinical pharmacokinetics 2008;47(3):203-16.
2007: Hirsh Jack; Agnelli Giancarlo; Ansell Jack E; Bauer Kenneth A; Esmon Charles T; Turpie Alexander G G
Development of an oral xa inhibitor: rationale and initial clinical results.
Clinical advances in hematology & oncology : H&O 2007;5(12 Suppl 18):1-20.
2007: Dunn A S; Spyropoulos A C; Turpie A G G
Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT).
Journal of thrombosis and haemostasis : JTH 2007;5(11):2211-8.
2007: Turpie A G G; Bauer K A; Caprini J A; Comp P C; Gent M; Muntz J E;
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison.
Journal of thrombosis and haemostasis : JTH 2007;5(9):1854-61.
2007: Tapson Victor F; Decousus Hervé; Pini Mario; Chong Beng H; Froehlich James B; Monreal Manuel; Spyropoulos Alex C; Merli Geno J; Zotz Rainer B; Bergmann Jean-François; Pavanello Ricardo; Turpie Alexander G G; Nakamura Mashio; Piovella Franco; Kakkar Ajay K; Spencer Frederick A; Fitzgerald Gordon; Anderson Frederick A;
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.
Chest 2007;132(3):936-45.
2007: Eriksson B I; Turpie A G G; Lassen M R; Prins M H; Agnelli G; Kälebo P; Gaillard M L; Meems L;
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery.
Journal of thrombosis and haemostasis : JTH 2007;5(8):1660-5.
2007: Hunt Richard H; Choquette Denis; Craig Brian N; De Angelis Carlo; Habal Flavio; Fulthorpe Gordon; Stewart John I; Turpie Alexander G G; Davis Paul
Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?
Canadian family physician Médecin de famille canadien 2007;53(7):1177-84.
2007: Sprigg Nikola; Gray Laura J; Bath Philip M W; Lindenstrøm Ewa; Boysen Gudrun; De Deyn Peter Paul; Friis Pal; Leys Didier; Marttila Reijo; Olsson Jan-Edwin; O'Neill Desmond; Ringelstein Erich Bernd; van der Sande Jan-Jacob; Turpie Alexander G G;
Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2007;16(4):180-4.
2007: Schellong S M; Beyer J; Kakkar A K; Halbritter K; Eriksson B I; Turpie A G G; Misselwitz F; Kälebo P
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1431-7.
2007: Fisher William D; Eriksson Bengt I; Bauer Kenneth A; Borris Lars; Dahl Ola E; Gent Michael; Haas Sylvia; Homering Martin; Huisman Menno V; Kakkar Ajay K; Kälebo Peter; Kwong Louis M; Misselwitz Frank; Turpie Alexander G G
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
Thrombosis and haemostasis 2007;97(6):931-7.
2007: Turpie Alexander G G
Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(6):1238-47.
2007: Cohen Alexander T; Turpie Alexander G G; Leizorovicz Alain; Olsson Carl-Gustav; Vaitkus Paul T; Goldhaber Samuel Z;
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?
Vascular medicine (London, England) 2007;12(2):123-7.
2007: Sprigg Nikola; Gray Laura J; Bath Philip M W; Lindenstrøm Ewa; Boysen Gudrun; De Deyn Peter Paul; Friis Pal; Leys Didier; Marttila Reijo; Olsson Jan-Edwin; O'Neill Desmond; Ringelstein Erich Bernd; van der Sande Jan-Jacob; Turpie Alexander G G;
Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).
Journal of the neurological sciences 2007;254(1-2):54-9.
2007: O'Donnell Martin J; Kearon Clive; Johnson Judy; Robinson Marlene; Zondag Michelle; Turpie Irene; Turpie Alexander G
Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.
Annals of internal medicine 2007;146(3):184-7.
2007: Turpie A G G
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?
Journal of thrombosis and haemostasis : JTH 2007;5(1):5-11.
2007: Kahn Susan R; Panju Akbar; Geerts William; Pineo Graham F; Desjardins Louis; Turpie Alexander G G; Glezer Stanislav; Thabane Lehana; Sebaldt Rolf J;
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Thrombosis research 2007;119(2):145-55.
2006: Turpie Alexander G G
Burden of disease: medical and economic impact of acute coronary syndromes.
The American journal of managed care 2006;12(16 Suppl):S430-4.
2006: Turpie Alexander G G; Leizorovicz Alain
Prevention of venous thromboembolism in medically ill patients: a clinical update.
Postgraduate medical journal 2006;82(974):806-9.
2006: Kearon Clive; Ginsberg Jeffrey S; Julian Jim A; Douketis James; Solymoss Susan; Ockelford Paul; Jackson Sharon; Turpie Alexander G; MacKinnon Betsy; Hirsh Jack; Gent Michael;
Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
JAMA : the journal of the American Medical Association 2006;296(8):935-42.
2006: Hull Russell D; Schellong Sebastian M; Tapson Victor F; Monreal Manuel; Samama Meyer-Michel; Turpie Alexander G G; Wildgoose Peter; Yusen Roger D
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.
Journal of thrombosis and thrombolysis 2006;22(1):31-8.
2006: Kearon Clive; Ginsberg Jeffrey S; Douketis James; Turpie Alexander G; Bates Shannon M; Lee Agnes Y; Crowther Mark A; Weitz Jeffrey I; Brill-Edwards Patrick; Wells Philip; Anderson David R; Kovacs Michael J; Linkins Lori-Ann; Julian Jim A; Bonilla Laura R; Gent Michael;
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial.
Annals of internal medicine 2006;144(11):812-21.
2006: Spyropoulos A C; Turpie A G G; Dunn A S; Spandorfer J; Douketis J; Jacobson A; Frost F J;
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1246-52.
2006: Gray L J; Sprigg N; Bath P M W; Sørensen P; Lindenstrøm E; Boysen G; De Deyn P P; Friis P; Leys D; Marttila R; Olsson J-E; O'Neill D; Ringelstein B; van der Sande J-J; Turpie A G G;
Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
Journal of neurology, neurosurgery, and psychiatry 2006;77(3):327-33.
2006: Cohen Alexander T; Davidson Bruce L; Gallus Alexander S; Lassen Michael R; Prins Martin H; Tomkowski Witold; Turpie Alexander G G; Egberts Jan F M; Lensing Anthonie W A;
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
BMJ (Clinical research ed.) 2006;332(7537):325-9.
2006: Colwell Clifford W; Kwong Lewis M; Turpie Alexander G G; Davidson Bruce L
Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.
The Journal of arthroplasty 2006;21(1):36-45.
2006: Natarajan Madhu K; Velianou James L; Turpie Alexander G G; Mehta Shamir R; Raco Dominic; Goodhart David M; Afzal Rizwan; Ginsberg Jeffrey S
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions.
American heart journal 2006;151(1):175.
2006: Turpie Alexander G G
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction.
Vascular health and risk management 2006;2(4):371-8.
2005: Piovella F; Wang C-J; Lu H; Lee K; Lee L H; Lee W C; Turpie A G G; Gallus A S; Planès A; Passera R; Rouillon A;
Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2664-70.
2005: Eikelboom John W; Quinlan Daniel J; Mehta Shamir R; Turpie Alexander G; Menown Ian B; Yusuf Salim
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Circulation 2005;112(25):3855-67.
2005: Turpie A G G; Fisher W D; Bauer K A; Kwong L M; Irwin M W; Kälebo P; Misselwitz F; Gent M;
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2479-86.
2005: Cohen Alexander T; Alikhan Raza; Arcelus Juan I; Bergmann Jean-François; Haas Sylvia; Merli Geno J; Spyropoulos Alex C; Tapson Victor F; Turpie Alexander G G
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
Thrombosis and haemostasis 2005;94(4):750-9.
2005: Abramson Beth L; Huckell Vic; Anand Sonia; Forbes Tom; Gupta Anil; Harris Ken; Junaid Asad; Lindsay Tom; McAlister Finlay; Roussin Andre; Saw Jacqueline; Teo Koon Kang; Turpie Alexander G; Verma Subodh;
Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.
The Canadian journal of cardiology 2005;21(12):997-1006.
2005: Spyropoulos Alex C; Turpie Alexander G G
Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation.
Current opinion in pulmonary medicine 2005;11(5):373-9.
2005: Turpie Alexander G G
Multidetector-row computed tomography in suspected pulmonary embolism.
The New England journal of medicine 2005;353(6):630-1; author reply 630-1.
2005: Seshadri Niranjan; Goldhaber Samuel Z; Elkayam Uri; Grimm Richard A; Groce James B; Heit John A; Spinler Sarah A; Turpie Alexander G G; Bosker Gideon; Klein Allan L
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients.
American heart journal 2005;150(1):27-34.
2005: Turpie Alexander G G
The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
Expert opinion on drug safety 2005;4(4):707-21.
2005: Douketis J D; Julian J A; Kearon C; Anderson D R; Crowther M A; Bates S M; Barone M; Piovella F; Turpie A G; Middeldorp S; van Nguyen P; Prandoni P; Wells P S; Kovacs M J; MacGillavry M R; Costantini L; Ginsberg J S
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study.
Journal of thrombosis and haemostasis : JTH 2005;3(5):943-8.
2005: Kovacs Michael J; Kearon Clive; Julian Jim A; Douketis James D; Demers Christine; Wells Philip S; Turpie Alexander G; Anderson David R; Kahn Susan R; Nguyen Paul V; Green David; Kassis Jeannine; Geerts William; Mackinnon Betsy; Ginsberg Jeffrey S
Influence of warfarin on symptoms of fatigue: findings of a randomized trial.
The Annals of pharmacotherapy 2005;39(5):840-2.
2005: Kearon Clive; Ginsberg Jeffrey S; Douketis James; Crowther Mark A; Turpie Alexander G; Bates Shannon M; Lee Agnes; Brill-Edwards Patrick; Finch Terri; Gent Michael
A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonography.
Annals of internal medicine 2005;142(7):490-6.
2005: Ageno Walter; Turpie Alexander G G
What's new for DVT prophylaxis for the medically ill.
Disease-a-month : DM 2005;51(2-3):194-9.
2005: Kucher Nils; Leizorovicz Alain; Vaitkus Paul T; Cohen Alexander T; Turpie Alexander G G; Olsson Carl-Gustav; Goldhaber Samuel Z
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.
Archives of internal medicine 2005;165(3):341-5.
2005: Leizorovicz A; Turpie A G G; Cohen A T; Wong L; Yoo M C; Dans A;
Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study.
Journal of thrombosis and haemostasis : JTH 2005;3(1):28-34.
2005: Vaitkus Paul T; Leizorovicz Alain; Cohen Alexander T; Turpie Alexander G G; Olsson Carl-Gustav; Goldhaber Samuel Z;
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.
Thrombosis and haemostasis 2005;93(1):76-9.
2005: Goldhaber Samuel Z; Turpie Alexander G G
Prevention of venous thromboembolism among hospitalized medical patients.
Circulation 2005;111(1):e1-3.
2005: Ageno Walter; Turpie Alexander G G
Clinical trials of deep vein thrombosis prophylaxis in medical patients.
Clinical cornerstone 2005;7(4):16-22.
2004: Turpie Alexander G G; Eriksson Bengt I; Bauer Kenneth A; Lassen Michael R
Fondaparinux.
The Journal of the American Academy of Orthopaedic Surgeons 2004;12(6):371-5.
2004: Lee A Y Y; Gent M; Julian J A; Bauer K A; Eriksson B I; Lassen M R; Turpie A G G
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review.
Journal of thrombosis and haemostasis : JTH 2004;2(10):1752-9.
2004: Kovacs M J; Kearon C; Rodger M; Anderson D R; Turpie A G G; Bates S M; Desjardins L; Douketis J; Kahn S R; Solymoss S; Wells P S
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Circulation 2004;110(12):1658-63.
2004: Turpie Alexander G G; Bauer Kenneth A; Eriksson Bengt I; Lassen Michael R
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.
Chest 2004;126(2):501-8.
2004: Leizorovicz Alain; Cohen Alexander T; Turpie Alexander G G; Olsson Carl-Gustav; Vaitkus Paul T; Goldhaber Samuel Z;
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Circulation 2004;110(7):874-9.
2004: Turpie Alexander G G; Norris Timothy M
Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
Thrombosis and haemostasis 2004;92(1):3-12.
2004: Douketis James D; Johnson Judith A; Turpie Alexander G
Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Archives of internal medicine 2004;164(12):1319-26.
2004: Turpie Alexander G G
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.
Expert opinion on pharmacotherapy 2004;5(6):1373-84.
2004: Turpie A G G
The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
International journal of clinical practice 2004;58(5):483-93.
2004: Alikhan Raza; Cohen Alexander T; Combe Sophie; Samama Meyer M; Desjardins Louis; Eldor Amiram; Janbon Charles; Leizorovicz Alain; Olsson Carl-Gustav; Turpie Alexander G G;
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
Archives of internal medicine 2004;164(9):963-8.
2004: Kearon C; Ginsberg J S; Anderson D R; Kovacs M J; Wells P; Julian J A; Mackinnon B; Demers C; Douketis J; Turpie A G; Van Nguyen P; Green D; Kassis J; Kahn S R; Solymoss S; Desjardins L; Geerts W; Johnston M; Weitz J I; Hirsh J; Gent M;
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.
Journal of thrombosis and haemostasis : JTH 2004;2(5):743-9.
2004: Desjardins Louis; Bara Lucienne; Boutitie Florent; Samama Meyer Michel; Cohen Alexander T; Combe Sophie; Janbon Charles; Leizorovicz Alain; Olsson Carl-Gustav; Turpie Alexander G G
Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study.
Archives of pathology & laboratory medicine 2004;128(5):519-26.
2004: Ageno Walter; Crotti Stefania; Turpie Alexander G G
The safety of antithrombotic therapy during pregnancy.
Expert opinion on drug safety 2004;3(2):113-8.
2004: Turpie A G G
Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
Surgical technology international 2004;13():261-7.
2003: Turpie Alexander G G; Eriksson Bengt I; Bauer Kenneth A; Lassen Michael R
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
Chest 2003;124(6 Suppl):371S-378S.
2003: Turpie Alexander G G
Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003;60(22 Suppl 7):S20-4.
2003: Turpie Alexander G G; Bauer Kenneth A; Eriksson Bengt I; Lassen Michael R
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet 2003;362(9395):1582-3.
2003: Turpie Alexander G G; Eriksson Bengt I; Lassen Michael R; Bauer Kenneth A
Fondaparinux, the first selective factor Xa inhibitor.
Current opinion in hematology 2003;10(5):327-32.
2003: Kearon Clive; Ginsberg Jeffrey S; Kovacs Michael J; Anderson David R; Wells Philip; Julian Jim A; MacKinnon Betsy; Weitz Jeffrey I; Crowther Mark A; Dolan Sean; Turpie Alexander G; Geerts William; Solymoss Susan; van Nguyen Paul; Demers Christine; Kahn Susan R; Kassis Jeannine; Rodger Marc; Hambleton Julie; Gent Michael;
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
The New England journal of medicine 2003;349(7):631-9.
2003: Alikhan Raza; Cohen Alexander T; Combe Sophie; Samama Meyer M; Desjardins Louis; Eldor Amiram; Janbon Charles; Leizorovicz Alain; Olsson Carl-Gustav; Turpie Alexander G G
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):341-6.
2003: Cannon Christopher P; Turpie Alexander G G
Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy.
Circulation 2003;107(21):2640-5.
2003: Dunn Andrew S; Turpie Alexander G G
Perioperative management of patients receiving oral anticoagulants: a systematic review.
Archives of internal medicine 2003;163(8):901-8.
2003: Turpie A G G
Choice of low molecular weight heparins.
Journal of thrombosis and haemostasis : JTH 2003;1(3):598.
2003: Eriksson B I; Bauer K A; Lassen M R; Turpie A G G
Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.
Journal of thrombosis and haemostasis : JTH 2003;1(2):383-4.
2002: Ageno W; Turpie A G G
Low molecular weight heparins in the treatment of unstable angina.
Minerva cardioangiologica 2002;50(6):643-51.
2002: Turpie Alexander G G
Use of selective factor Xa inhibitors in special populations.
American journal of orthopedics (Belle Mead, N.J.) 2002;31(11 Suppl):11-5.
2002: Goldsmith Ira; Turpie Alexander G G; Lip Gregory Y H
Valvar heart disease and prosthetic heart valves.
BMJ (Clinical research ed.) 2002;325(7374):1228-31.
2002: Turpie Alexander G G; Chin Bernard S P; Lip Gregory Y H
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies.
BMJ (Clinical research ed.) 2002;325(7370):948-50.
2002: Turpie Alexander G G; Chin Bernard S P; Lip Gregory Y H
Venous thromboembolism: pathophysiology, clinical features, and prevention.
BMJ (Clinical research ed.) 2002;325(7369):887-90.
2002: Ageno Walter; Turpie Alexander G
Deep venous thrombosis in the medically ill.
Current hematology reports 2002;1(1):73-8.
2002: Turpie Alexander G G; Bauer Kenneth A; Eriksson Bengt I; Lassen Michael R
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Archives of internal medicine 2002;162(16):1833-40.
2002: Bauer Kenneth A; Eriksson Bengt I; Lassen Michael R; Turpie Alexander G G
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Current opinion in pulmonary medicine 2002;8(5):398-404.
2002: Turpie Alexander G G
State of the art--a journey through the world of antithrombotic therapy.
Seminars in thrombosis and hemostasis 2002;28 Suppl 3():3-11.
2002: Turpie Alexander G G
Pentasaccharides.
Seminars in hematology 2002;39(3):158-71.
2002: Turpie Alexander G G; Büller Harry R
Benefit of selective factor inhibition.
Seminars in thrombosis and hemostasis 2002;28 Suppl 2():49-50.
2002: Turpie Alexander G G
Optimizing prophylaxis of venous thromboembolism.
Seminars in thrombosis and hemostasis 2002;28 Suppl 2():25-32.
2002: Turpie Alexander G G; Bauer Kenneth A; Eriksson Bengt I; Lassen Michael R;
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
Lancet 2002;359(9319):1721-6.
2002: Lassen Michael Rud; Bauer Kenneth A; Eriksson Bengt I; Turpie Alexander G G;
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
Lancet 2002;359(9319):1715-20.
2002: Turpie Alexander G G; Mason Jacqueline A
Review of enoxaparin and its clinical applications in venous and arterial thromboembolism.
Expert opinion on pharmacotherapy 2002;3(5):575-98.
2002: Ageno Walter; Turpie Alexander G G
New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(7):919-24.
2002: Bauer Kenneth A; Eriksson Bengt I; Lassen Michael R; Turpie Alexander G G
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.
Journal of the Southern Orthopaedic Association 2002;11(4):197-202.
2002: Turpie Alexander G G; Eriksson Bengt I; Lassen Michael R; Bauer Kenneth A
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Journal of the Southern Orthopaedic Association 2002;11(4):182-8.
2001: Bauer K A; Eriksson B I; Lassen M R; Turpie A G;
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
The New England journal of medicine 2001;345(18):1305-10.
2001: Eriksson B I; Bauer K A; Lassen M R; Turpie A G;
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
The New England journal of medicine 2001;345(18):1298-304.
2001: Turpie A G
Setting a standard for venous thromboembolism prophylaxis.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2001;58 Suppl 2():S18-23.
2001: Bath P M; Lindenstrom E; Boysen G; De Deyn P; Friis P; Leys D; Marttila R; Olsson J; O'Neill D; Orgogozo J; Ringelstein B; van der Sande J; Turpie A G
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
Lancet 2001;358(9283):702-10.
2001: Turpie A G
Pentasaccharide Org31540/SR90107A clinical trials update: lessons for practice.
American heart journal 2001;142(2 Suppl):S9-15.
2001: Ageno W; Turpie A G; Steidl L; Ambrosini F; Cattaneo R; Codari R L; Nardo B; Venco A
Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.
The American journal of cardiology 2001;88(1):40-4.
2001: Turpie A G
Looking forward in the treatment of deep-vein thrombosis.
Seminars in hematology 2001;38(2 Suppl 5):49-57.
2001: Holper E M; Antman E M; McCabe C H; Premmereur J; Gurfinkel E; Bernink P J; Turpie A G; Bayes de Luna A; Lablanche J M; Fox K M; Salein D; Radley D R; Braunwald E
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.
The American journal of cardiology 2001;87(8):1008-10; A5.
2001: Turpie A G; Gallus A S; Hoek J A;
A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
The New England journal of medicine 2001;344(9):619-25.
2000: Turpie A G
Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial.
The American journal of cardiology 2000;86(12B):48M-52M.
2000: Cohen M; Antman E M; Gurfinkel E; Turpie A G; Furst J; Bigonzi F; Radley D
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction.
The American journal of cardiology 2000;86(5):553-6, A9.
2000: Goodman S G; Cohen M; Bigonzi F; Gurfinkel E P; Radley D R; Le Iouer V; Fromell G J; Demers C; Turpie A G; Califf R M; Fox K A; Langer A
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.
Journal of the American College of Cardiology 2000;36(3):693-8.
2000: Ageno W; Johnson J; Nowacki B; Turpie A G
A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy.
Thrombosis and haemostasis 2000;83(6):849-52.
2000: Wells P S; Anderson D R; Rodger M; Ginsberg J S; Kearon C; Gent M; Turpie A G; Bormanis J; Weitz J; Chamberlain M; Bowie D; Barnes D; Hirsh J
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.
Thrombosis and haemostasis 2000;83(3):416-20.
2000: Turpie A G
Can we differentiate the low-molecular-weight heparins?
Clinical cardiology 2000;23 Suppl 1():I4-7.
2000: Ageno W; Turpie A G
Therapy of unstable angina with the low molecular weight heparins.
Vascular medicine (London, England) 2000;5(4):217-23.
2000: Turpie A G
Antithrombotics and anticoagulants in coronary syndromes and stroke.
Seminars in thrombosis and hemostasis 2000;26 Suppl 1():79-83.
1999: Antman E M; McCabe C H; Gurfinkel E P; Turpie A G; Bernink P J; Salein D; Bayes De Luna A; Fox K; Lablanche J M; Radley D; Premmereur J; Braunwald E
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Circulation 1999;100(15):1593-601.
1999: Turpie A G
Anticoagulants in acute coronary syndromes.
The American journal of cardiology 1999;84(5A):2M-6M.
1999: Samama M M; Cohen A T; Darmon J Y; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson C G; Turpie A G; Weisslinger N
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
The New England journal of medicine 1999;341(11):793-800.
1999: Turpie A G
Customizing our approach in deep vein thrombosis and pulmonary embolism treatment: overview of our clinical experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10 Suppl 2():S107-15.
1999: Kearon C; Gent M; Hirsh J; Weitz J; Kovacs M J; Anderson D R; Turpie A G; Green D; Ginsberg J S; Wells P; MacKinnon B; Julian J A
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
The New England journal of medicine 1999;340(12):901-7.
1998: Wells P S; Ginsberg J S; Anderson D R; Kearon C; Gent M; Turpie A G; Bormanis J; Weitz J; Chamberlain M; Bowie D; Barnes D; Hirsh J
Use of a clinical model for safe management of patients with suspected pulmonary embolism.
Annals of internal medicine 1998;129(12):997-1005.
1998: Ginsberg J S; Wells P S; Kearon C; Anderson D; Crowther M; Weitz J I; Bormanis J; Brill-Edwards P; Turpie A G; MacKinnon B; Gent M; Hirsh J
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism.
Annals of internal medicine 1998;129(12):1006-11.
1998: Turpie A G; Kher A
Prevention of venous thrombosis after elective hip surgery.
Orthopedics 1998;21(12):1275-81.
1998: Ageno W; Turpie A G
A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy.
Thrombosis research 1998;91(5):237-40.
1998: Cohen M; Demers C; Gurfinkel E P; Turpie A G; Fromell G J; Goodman S; Langer A; Califf R M; Fox K A; Premmereur J; Bigonzi F
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
The American journal of cardiology 1998;82(5B):19L-24L.
1998: Turpie A G
Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
The Canadian journal of cardiology 1998;14 Suppl E():20E-23E.
1998: Turpie A G
Pharmacology of the low-molecular-weight heparins.
American heart journal 1998;135(6 Pt 3 Su):S329-35.
1998: Mark D B; Cowper P A; Berkowitz S D; Davidson-Ray L; DeLong E R; Turpie A G; Califf R M; Weatherley B; Cohen M
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction].
Circulation 1998;97(17):1702-7.
1997: Ray J G; Turpie A G
Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.
The Canadian journal of cardiology 1997;13(12):1162-5.
1997: Turpie A G
Successors to heparin: new antithrombotic agents.
American heart journal 1997;134(5 Pt 2):S71-7.
1997: Turpie A G
New frontiers in the management of unstable coronary artery disease.
The American journal of cardiology 1997;80(5A):21E-24E.
1997: Cohen M; Demers C; Gurfinkel E P; Turpie A G; Fromell G J; Goodman S; Langer A; Califf R M; Fox K A; Premmereur J; Bigonzi F
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
The New England journal of medicine 1997;337(7):447-52.
1997: Turpie A G
Antithrombotic therapy following heart valve replacement.
Thrombosis and haemostasis 1997;78(1):382-5.
1997: Ginsberg J S; Kearon C; Douketis J; Turpie A G; Brill-Edwards P; Stevens P; Panju A; Patel A; Crowther M; Andrew M; Massicotte P; Hirsh J; Weitz J I
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis.
Archives of internal medicine 1997;157(10):1077-81.
1997: Turpie A G
Low-molecular-weight heparin: from the bench to the orthopedic patient.
Orthopedics 1997;20 Suppl():10-3.
1997: Turpie A G
Prophylaxis of venous thromboembolism in stroke patients.
Seminars in thrombosis and hemostasis 1997;23(2):155-7.
1996: Levine M N; Gent M; Hirsh J; Weitz J; Turpie A G; Powers P; Neemeh J; Willan A; Skingley P
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
Archives of internal medicine 1996;156(8):851-6.
1996: Levine M; Gent M; Hirsh J; Leclerc J; Anderson D; Weitz J; Ginsberg J; Turpie A G; Demers C; Kovacs M
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
The New England journal of medicine 1996;334(11):677-81.
1996: Gent M; Hirsh J; Ginsberg J S; Powers P J; Levine M N; Geerts W H; Jay R M; Leclerc J; Neemeh J A; Turpie A G
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
Circulation 1996;93(1):80-4.
1995: Levine M N; Hirsh J; Gent M; Turpie A G; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
Thrombosis and haemostasis 1995;74(2):606-11.
1995: Turpie A G; Weitz J I; Hirsh J
Advances in antithrombotic therapy: novel agents.
Thrombosis and haemostasis 1995;74(1):565-71.
1995: Turpie A G
Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.
Orthopedics 1995;18 Suppl():15-7.
1994: Levine M N; Hirsh J; Gent M; Turpie A G; Cruickshank M; Weitz J; Anderson D; Johnson M
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
Archives of internal medicine 1994;154(1):49-56.
1993: Turpie A G; Gent M; Laupacis A; Latour Y; Gunstensen J; Basile F; Klimek M; Hirsh J
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
The New England journal of medicine 1993;329(8):524-9.
1992: Turpie A G; Gent M; Côte R; Levine M N; Ginsberg J S; Powers P J; Leclerc J; Geerts W; Jay R; Neemeh J
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
Annals of internal medicine 1992;117(5):353-7.
1992: Turpie A G
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Haemostasis 1992;22(2):92-8.
1991: Turpie A G
Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis.
American journal of surgery 1991;161(4):532-6.
1991: Levine M N; Hirsh J; Gent M; Turpie A G; Leclerc J; Powers P J; Jay R M; Neemeh J
Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
Annals of internal medicine 1991;114(7):545-51.
1990: Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie A G; Gent M
A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Chest 1990;98(6):1473-9.
1990: Turpie A G; Levine M N; Hirsh J; Ginsberg J S; Cruickshank M; Jay R; Gent M
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Chest 1990;97(4 Suppl):172S-175S.
1990: Levine M N; Weitz J; Turpie A G; Andrew M; Cruickshank M; Hirsh J
A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease.
Chest 1990;97(4 Suppl):168S-171S.
1990: Turpie A G
Anticoagulant therapy after acute myocardial infarction.
The American journal of cardiology 1990;65(6):20C-23C.
1990: Turpie A G
Enoxaparin prophylaxis in elective hip surgery.
Acta chirurgica Scandinavica. Supplementum 1990;556():103-7.
1989: Turpie A G
Therapy of deep vein thrombosis.
Herz 1989;14(6):341-7.
1989: Cruickshank M K; Levine M N; Hirsh J; Turpie A G; Powers P; Jay R; Gent M
An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgery.
Thrombosis and haemostasis 1989;62(3):830-4.
1989: Ginsberg J S; Shin A; Turpie A G; Hirsh J
Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography.
Archives of internal medicine 1989;149(10):2255-7.
1989: Gent M; Blakely J A; Easton J D; Ellis D J; Hachinski V C; Harbison J W; Panak E; Roberts R S; Sicurella J; Turpie A G
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.
Lancet 1989;1(8649):1215-20.
1989: Powers P J; Gent M; Jay R M; Julian D H; Turpie A G; Levine M; Hirsh J
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
Archives of internal medicine 1989;149(4):771-4.
1989: Turpie A G; Hirsh J; Gent M; Julian D; Johnson J
Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control.
Archives of internal medicine 1989;149(3):679-81.
1989: Turpie A G; Robinson J G; Doyle D J; Mulji A S; Mishkel G J; Sealey B J; Cairns J A; Skingley L; Hirsh J; Gent M
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
The New England journal of medicine 1989;320(6):352-7.
1989: Turpie A G; Bloch R; Duke R
Heparin in the treatment of thromboembolic stroke.
Annals of the New York Academy of Sciences 1989;556():406-15.
1988: Gent M; Blakely J A; Easton J D; Ellis D J; Hachinski V C; Harbison J W; Panak E; Roberts R S; Sicurella J; Turpie A G
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.
Stroke; a journal of cerebral circulation 1988;19(10):1203-10.
1988: Turpie A G
Clinical studies: evidence for intervention with specific antiplatelet drugs in arterial thromboembolism.
Seminars in thrombosis and hemostasis 1988;14(1):41-9.
1988: Turpie A G
Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
Acta chirurgica Scandinavica. Supplementum 1988;543():85-6.
1987: Turpie A G; Levine M N; Hirsh J; Carter C J; Jay R M; Powers P J; Andrew M; Magnani H N; Hull R D; Gent M
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
Lancet 1987;1(8532):523-6.
1986: Turpie A G; Levine M N; Hirsh J; Carter C J; Jay R M; Powers P J; Andrew M; Hull R D; Gent M
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
The New England journal of medicine 1986;315(15):925-9.
1985: Hull R D; Hirsh J; Carter C J; Jay R M; Ockelford P A; Buller H R; Turpie A G; Powers P; Kinch D; Dodd P E
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial.
Annals of internal medicine 1985;102(1):21-8.
1983: Hull R D; Hirsh J; Carter C J; Jay R M; Dodd P E; Ockelford P A; Coates G; Gill G J; Turpie A G; Doyle D J; Buller H R; Raskob G E
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan.
Annals of internal medicine 1983;98(6):891-9.
1983: Hull R D; Carter C J; Jay R M; Ockelford P A; Hirsch J; Turpie A G; Zielinsky A; Gent M; Powers P J
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.
Circulation 1983;67(4):901-6.
1982: Zielinsky A; Hirsh J; Straumanis G; Carter C J; Gent M; Sackett D L; Hull R; Kelton J G; Powers P; Turpie A G
The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosis.
Blood 1982;59(2):346-50.
1981: Hull R; Hirsh J; Sackett D L; Taylor D W; Carter C; Turpie A G; Zielinsky A; Powers P; Gent M
Replacement of venography in suspected venous thrombosis by impedance plethysmography and 125I-fibrinogen leg scanning: a less invasive approach.
Annals of internal medicine 1981;94(1):12-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Alexander Turpie

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Alexander Turpie (preview)

All Publications